NASDAQ · OGI
Organigram Global financials
$1.07−1.38%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Sep 30 | FY24 Sep 30 | FY22 Aug 31 | FY21 Aug 31 | FY20 Aug 31 | FY19 Aug 31 |
|---|---|---|---|---|---|---|
| Revenue | $186.1M | $118.2M | $111.0M | $62.7M | $66.6M | $60.2M |
| Gross profit | $60.6M | $35.8M | $20.4M | -$19.3M | -$14.0M | $28.4M |
| Gross margin | 32.5% | 30.3% | 18.4% | −30.8% | −21.0% | 47.1% |
| Operating income | -$15.2M | -$25.0M | -$36.5M | -$69.6M | -$82.2M | -$3.8M |
| Net income | -$17.8M | -$33.6M | -$10.9M | -$103.6M | -$104.4M | -$7.1M |
| Net margin | −9.6% | −28.4% | −9.8% | −165.1% | −156.9% | −11.9% |
| Diluted EPS | $-0.14 | $-0.35 | $-0.14 | $-1.62 | $-2.42 | $-0.20 |
| EBITDA | -$2.3M | -$16.1M | -$14.3M | -$36.4M | -$38.0M | $3.3M |
| Operating cash flow | -$5.5M | $2.9M | -$27.6M | -$22.7M | -$34.6M | -$26.3M |
| Free cash flow | -$17.7M | -$635.0K | -$64.6M | -$32.0M | -$93.8M | -$107.6M |
| Diluted shares | 127.7M | 95.3M | 77.2M | 64.0M | 44.5M | 37.9M |
Balance sheet
| Period end | Sep 30 | Sep 30 | Sep 30 | Aug 31 | Aug 31 | Aug 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $20.3M | $78.9M | $24.9M | $52.1M | $43.9M | $18.9M |
| Short-term investments | $593.2K | $606.9K | $0.00 | $22.9M | $101.6M | $38.4M |
| Total debt | $0.00 | $0.00 | $58.1K | $178.8K | $245.7K | $88.4M |
| Total assets | $403.8M | $301.5M | $219.6M | $439.1M | $439.1M | $333.8M |
| Total liabilities | $153.0M | $75.3M | $19.7M | $52.5M | $58.8M | $104.0M |
| Shareholders' equity | $250.7M | $226.2M | $199.9M | $386.6M | $380.3M | $229.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology